US › Healthcare

Akanda Corp (AKAN)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.20-8.40%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$404,394

Revenue YoY

-15.2%

Net profit

$-6.2M

EPS

$-2.02

EPS estimate

$0.00

Net margin

-1,532.3%

Key statistics

Market cap

$3.5M

Forward P/E

0.0

P/B

2.21

Book value

$-19.37

EPS (TTM)

$-14,239.41

52-week high

$78.90

52-week low

$1.27

50-day MA

$3.45

200-day MA

$8.95

Beta

14.19

Shareholding

Insiders

0.59%

Institutions

0.08%

Largest institutional holders

Fund	Stake
Integrated Wealth Concepts LLC	0.08%
UBS Group AG	0.03%
Wells Fargo & Co	0.00%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Akanda Corp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.